SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 26th, 2024 • Inmune Bio, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 24, 2024, between INmune Bio Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 26th, 2024 • Inmune Bio, Inc. • Biological products, (no disgnostic substances) • New York
